P2X7 receptor regulates osteoclast function and bone loss in a mouse model of osteoporosis
Abstract Post-menopausal osteoporosis is a condition that affects millions worldwide and places a huge socio-economic burden on society. Previous research has shown an association of loss of function SNPs in the gene for the purinergic receptor P2X7R with low bone mineral density, increased rates of...
Guardado en:
Autores principales: | Ning Wang, Ankita Agrawal, Niklas Rye Jørgensen, Alison Gartland |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/593ec7c4879b49588c24789f6eff118a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ELMO1 signaling is a promoter of osteoclast function and bone loss
por: Sanja Arandjelovic, et al.
Publicado: (2021) -
Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss.
por: Yoshiki Nakashima, et al.
Publicado: (2013) -
Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins
por: David E. Place, et al.
Publicado: (2021) -
Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss
por: Jinhu Xiong, et al.
Publicado: (2018) -
Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity
por: Huang JM, et al.
Publicado: (2021)